Middle East Companion Animal Healthcare Market, by End User, 2018-2027
| Label | Anti-Infectives | Antibiotics | Anti-Inflammatories | Others |
|---|---|---|---|---|
| 2018 | 312.74 USD Mn | 235.63 USD Mn | 156.6 USD Mn | 234.17 USD Mn |
| 2019 | 333.52 USD Mn | 250.93 USD Mn | 168.96 USD Mn | 251.15 USD Mn |
| 2020 | 352.13 USD Mn | 264.55 USD Mn | 180.46 USD Mn | 266.67 USD Mn |
| 2021 | 377.8 USD Mn | 283.42 USD Mn | 195.86 USD Mn | 287.74 USD Mn |
| 2022 | 406.05 USD Mn | 304.17 USD Mn | 212.93 USD Mn | 311.02 USD Mn |
| 2023 | 437.19 USD Mn | 327.02 USD Mn | 231.88 USD Mn | 336.78 USD Mn |
| 2024 | 471.58 USD Mn | 352.22 USD Mn | 252.97 USD Mn | 365.35 USD Mn |
| 2025 | 509.63 USD Mn | 380.07 USD Mn | 276.48 USD Mn | 397.08 USD Mn |
| 2026 | 551.81 USD Mn | 410.9 USD Mn | 302.73 USD Mn | 432.39 USD Mn |
| 2027 | 598.64 USD Mn | 445.1 USD Mn | 332.11 USD Mn | 471.77 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the Middle East Companion Animal Healthcare Market, by Pharmaceuticals, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 1698 Mn in 2026 and is projected to reach USD 1848 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
- Anti-Infectives is the biggest of 4 groups as of 2027, at 598. 64M USD (32% of the combined total).
- What the regional split looks like (2026): Anti-Infectives leads, holding roughly 33% of segment value — the single largest regional share. Others is the second-largest contributor. Antibiotics and Anti-Inflammatories make up the remainder, in descending order.
- By 2027, Anti-Infectives alone is expected to reach USD 599 Mn, with Others at USD 472 Mn.
Market Dynamics
Anti-Infectives is the biggest of 4 groups as of 2027, at 598.64M USD (32% of the combined total).
Others follows at 471.77M USD, 21% smaller than Anti-Infectives.
Anti-Infectives climbs from 312.74M USD (2018) to 598.64M USD (2027), a 91% gain.
Others: 234.17M USD in 2018 to 471.77M USD by 2027, up 101%.
Antibiotics: 235.63M USD to 445.10M USD, 89% higher by 2027.
Anti-Inflammatories grows to 332.11M USD by 2027, from 156.60M USD in 2018 — 112% up.
Anti-Inflammatories grows fastest of the group, 112% from 2018 to 2027 — starting smaller doesn't mean staying smaller at this pace.
Add every series together and the total reaches 1.85B USD by 2027, 97% above the 2018 combined figure of 939.14M USD.
Who Leads, And By How Much
This chart compares 4 series side by side, not one trend over time. Read them against each other — the biggest number in the room is not automatically the most important line to follow.
The largest series today is not guaranteed to stay largest — check the growth rate of each group, not just its current size, before projecting the ranking forward.
The most practical way to read this is relative: set the Middle East Companion Animal Healthcare market figures beside other regions or segments of the same market to see where growth is concentrated.
Figures before the 2018 base year are historical estimates; the years through 2027 are projections built from industry data, company revenues, and primary interviews. Forecasts are revised as new data comes in, so check the full report for the latest assumptions.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Charts From Same Market
View AllMiddle East Companion Animal Healthcare Market, by Diagnostics, 2018-2027
Middle East Companion Animal Healthcare Market, by Feed Additives, 2018-2027
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



